首页 › 基金 › Revelation Capital Management, LLC › VRDN

Revelation Capital Management, LLC 对 VRDN 的持仓历史

OBSIDIAN THERAPEUTICS INC · 医疗保健

Revelation Capital Management, LLC 在 Q3 2026 的 13F 申报中披露持有 VRDN(OBSIDIAN THERAPEUTICS INC)428,346 股,市值约 US$5.9M,约占其申报组合的 73.40%,在其申报持仓中市值排名第 1 位。 Revelation Capital Management, LLC 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)428.35K 股
申报持仓市值$5.88M
组合权重73.40%
首次申报Q3 2026
最近变动新进
更新于2026-11-03

最后更新: 2026-11-03 · 来源: SEC EDGAR Form 13F-HR

Revelation Capital Management, LLC 对 VRDN 的持仓演变

Revelation Capital Management, LLC 于 Q3 2026 首次披露 VRDN 持仓:428,346 股(约 US$5.9M)。

逐季持仓明细

季度股数金额变化
Q3 2026 428.35K $5.88M 新进

关于 VRDN 与 13F 数据

VRDN(OBSIDIAN THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 37 只申报持有 VRDN,申报仓位最大的包括:Bellevue Group AG (US$123.7M), Paradigm Biocapital Advisors LP (US$123.5M), Kynam Capital Management, LP (US$118.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 VRDN 的基金

查看 VRDN 的全部基金持有人 →

常见问题

How long has Revelation Capital Management, LLC held VRDN?

Revelation Capital Management, LLC has disclosed VRDN holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Revelation Capital Management, LLC's current position in VRDN?

As of Q3 2026, Revelation Capital Management, LLC holds 428.35K shares of VRDN (OBSIDIAN THERAPEUTICS INC), valued at $5.88M, representing 73.40% of its reported portfolio and ranking #1.

Has Revelation Capital Management, LLC been buying or selling VRDN?

In the latest 13F filing (Q3 2026), Revelation Capital Management, LLC newly opened its position in VRDN.

Which other funds hold VRDN?

Other major institutional holders of VRDN include Bellevue Group AG, Paradigm Biocapital Advisors LP, Kynam Capital Management, LP, among 37 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.